Boyd Biomedical Releases Comprehensive Study on Patient Monitoring Device Commercialization

Lee, Massachusetts - Boyd Biomedical announced the release of a comprehensive study examining the rapidly expanding patient monitoring device market and the integrated approach required for commercial success. The study includes an in-depth report alongside a series of articles, interactive tools, and an innovator spotlight from the Company’s video series Design Build Launch with Boyd Biomedical. 

The key findings from the study are detailed in the report Patient Monitoring Devices: The Complete Guide, which reveals significant benefits to healthcare systems along with several significant market opportunities across patient monitoring applications: 

• $40 billion global wearable medical device market with patient monitoring growing at 17% annually
• $5,000-$12,000 in direct cost savings per patient through remote monitoring-enabled early discharge
• 30-40% cost savings demonstrated by hospital-at-home programs using continuous monitoring
• Post-surgical monitoring market reaching $3.5 billion with 19% annual growth

In the video series, Dr. John Bloom and David Linders, co-founders of Podimetrics, share insights from building a breakthrough remote patient monitoring platform. They discuss how their involvement in MIT’s first “hacking healthcare” hackathon evolved into a company that has delivered $99.9 million in healthcare savings and reduced mortality of their patients by 37%. "The problem is actually the most important thing," explains Linders. "We didn't come in with the technology. We've been persistently going after this problem with whatever solution we need."

“So many startups attempting to enter the biomedical market fail - not from lack of innovation - but from fragmented execution. The path to success is narrow and it requires integrated execution across design, manufacturing, and commercialization. Companies treating these as separate phases typically struggle, especially when they believe they have a superior technology that will make up for poor execution."

MATTHEW BOYD
Chief Commercial Officer, Boyd Biomedical

Frameworks for Integrated Success

The study provides medical device companies with a series of articles delivering actionable guidance across the development lifecycle:

• Adhesive Engineering for Patient Monitoring Devices explores how design decisions about adhesives affect manufacturing feasibility and market adoption.
• Scaling Patient Monitoring Device Manufacturing examines how the transition from prototype to commercial production impacts success rates.
• Building the Evidence Strategy for Patient Monitoring Devices reveals how evidence strategies hold the key to both regulatory approval and healthcare system adoption.
• Post-Surgical Patient Monitoring: Capturing the $3.5B Opportunity analyzes how post-pandemic acceptance of remote care is driving growth in certain clinical areas.
• Stick-to-Skin Medical Devices: From Monitoring to Precision Healthcare outlines the market transformation and emerging technology trends shaping the industry's future.

Central to these frameworks is what Boyd Biomedical calls “integrated excellence", where design, manufacturing, and marketing disciplines work in collaborative teams and integrated commercial phases to deliver more effective commercialization. 

Practical Tools for Commercialization

The study also includes interactive tools to support decision making:

• Design Decision Guide for Stick-to-Skin Devices provides a comprehensive selection guide for optimizing stick-to-skin device design based on application requirements, including adhesive technology, wear duration, patient activity levels, and cost structure analysis.
• Manufacturing Cost Calculator for Stick-to-Skin Devices provides and interactive calculator to estimate manufacturing costs across different volumes and complexity levels.
• Time-to-Market ROI Calculator provides a framework for calculating the financial value of accelerating device launches through experienced commercialization partnerships.

Capitalizing on Healthcare's Shift to Continuous Monitoring

The study comes as healthcare systems permanently shift toward continuous patient monitoring due to hospital capacity constraints. Medicare's Hospital-at-Home waiver program has been extended due to demonstrated cost savings, while the aging population and rise of chronic diseases create sustained demand for monitoring solutions.

The patient monitoring device market opportunity is substantial and growing," said Stephen Boyd, CEO of Boyd Biomedical. "Healthcare's shift toward continuous monitoring, proactive intervention, and home-based care creates demand for sophisticated stick-to-skin devices. But capturing this opportunity requires manufacturing precision that simultaneously satisfies medical device quality standards and consumer electronics cost structures - a combination that challenges traditional approaches."